Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02928484

Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function

Evaluación Del Efecto Del Suplemento Nutricional probiótico Biopolis Sobre la función Gastrointestinal

Sponsor: Biopolis S.L.

Conditions Dyspepsia Signs and Symptoms, Digestive

Interventions Placebo Probiotic mix CBP-004019/C

Updated 6 times since 2017 Last updated: Oct 7, 2016 Started: Jun 30, 2016 Primary completion: Jun 30, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Dyspepsia and Signs and Symptoms, Digestive, this trial is ongoing. The trial is conducted by Biopolis S.L. and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Nov 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status
Jun 2018 — Nov 2018 [monthly]

Recruiting PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE1_PHASE2

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biopolis S.L.
Hospital Universitario Central de Asturias
National Research Council, Spain

Data source: Biopolis S.L.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oviedo, Spain